Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis

Author:Kieseier, Bernd   Montalban, Xavier   Williams, Mitzi   Airas, Laura   Saini, Sarbjit   Hide, Michihiro   Sussman, Gordon   Nakahara, Jin   Bermel, Robert   Doerner, Thomas   Loop, Brett   DeLasHeras, Virginia   Willi, Roman   Haemmerle, Sibylle   Zharkov, Artem   Barbier, Nathalie   Azmon, Amin   Siegel, Richard   Cenni, Bruno   Wiendl, Heinz   Maurer, Marcus   Gimenez-Arnau, Ana   Chitnis, Tanuja   

Session Name:P8: Multiple Sclerosis: Non-MS CNS Neuroinflammatory Diseases and Progressive MS and Remyelination/Neuroprotection  

Topic:Multiple Sclerosis  

Program Number:P8.015  

Author Institution:Novartis Pharma AG, Basel, Switzerland  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain  Joi Life Wellness Group, Atlanta, GA  Turku University Hospital and University of Turku, Turku, Finland  Johns Hopkins Asthma and Allergy Center, Baltimore, MD  Hiroshima Citizens Hospital, Minami-ku, Japan  University of Toronto, Toronto, ON, Canada  Department of Neurology, Keio University School of Medicine, Tokyo, Japan  Mellen Center for MS, Cleveland Clinic, Cleveland, OH  Department of Rheumatology and Clinical Immunology, Charite – Universitätsmedizin Berlin, Berlin, Germany  Novartis Pharmaceutical Corporation, Cambridge, MA  Novartis Institutes for Biomedical Research, Basel, Switzerland  Department of Neurology with Institute of Translational Neurology, University of Münster, Muenster, Germany  Urticaria Center of Reference and Excellence, Institute of Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany  Department of Dermatology, Hospital del Mar – IMIM, Universitat Pompeu Fabra, Barcelona, Spain  Department of Neurology, Brigham and Women's Hospital, Boston, MA  

Low MOG Expression in Human Thymus, Implications for Central Tolerance Mechanisms in Autoimmunity Against MOG

A Brain Care Score for Risk of Late-life Depression: Data from the UK Biobank Cohort

Author:Singh, Sanjula   Rivier, Cyprien   Oreskovic, Tin   Carr, Sinclair   Papier, Keren   Chemali, Zeina   Gutierrez-Martinez, Leidys   Mallick, Akashleena   Parodi, Livia   Mayerhofer, Ernst   Senff, Jasper   Kourkoulis, Christina   Marini, Sandro   Clocchiatti-Tuozzo, Santiago   Nunley, Courtney   Newhouse, Amy   Ouyang, An   Westover, Brandon   Lazar, Ronald   Pikula, Aleksandra   Ibrahim, Sarah   Brouwers, Bart   Howard, Virgina   Howard, George   Yechoor, Nirupama   van Duijn, Cornelia   Littlejohns, Thomas   Sheth, Kevin   Rosand, Jonathan   Gricchione, Gregory   Anderson, Christopher   Falcone, Guido   

Session Name:P10: Neuroepidemiology 4  

Topic:Global Health and Neuroepidemiology  

Program Number:P10.001  

Author Institution:Massachusetts General Hospital, Boston, MA  Yale University, New Haven, CT  University of Oxford, Oxford, United Kingdom  University of Washington, Roxbury, MA  Massachusetts General Hospital- Harvard Medical School, Boston, MA  McCance Center for Brain Health, Sommerville, MA  Yale University, Department of Neurology, New Haven, CT  Massachusetts General Hospital, Charlestown, MA  University of Alabama at Birmingham, Birmingham, AL  University of Toronto, Toronto, ON  University Medical Center Utrecht, Utrecht, Netherlands  UAB School of Public Hlth, Birmingham, AL  MassGeneral Brigham, Somerville, MA  Yale UniversityDivision of Neuro and Critical Care, New Haven, CT  Brigham and Women's Hospital, Boston, MA  Yale School of Medicine, New Haven, CT